Atlas Trials

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

Clinical trial NCT01881763 · COMPLETED

Trial details

NCT number
NCT01881763
Sponsor
Northwell Health
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Unipolar DepressionBipolar Depression
Start date
2010-06-01
Primary completion
2017-03-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.